Executive Summary
On January 2, 2026, an unprecedented cluster of 34 Form 8-K filings under Item 5.02 disclosed executive and director changes across diverse US sectors, marking unusually high turnover volume for a single day and potentially signaling year-start succession activity or governance resets. All filings share neutral sentiment, low-to-medium risk profiles, and critically, a uniform lack of specifics on officers, positions, reasons, or compensation, limiting immediate materiality but amplifying the need for follow-up analysis. This pattern suggests minimal acute market disruption but flags potential systemic leadership flux, with portfolio managers advised to monitor for correlated details revealing sector instability or opportunistic hires.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from December 30, 2025.
Investment Signals(4)
- ▲
Routine executive changes in stable large-caps like Aon plc [BULLISH] - Aon plc
- ▲
Elevated turnover volume in small-cap tech/biotech [BEARISH] - Super Micro Computer, MiNK Therapeutics, Indaptus Therapeutics
- ▲
Neutral sentiment amid high filing cluster indicates no panic selling trigger [BULLISH] - Broad market
- ▲
Banking sector filings with low materiality suggest non-disruptive updates [BULLISH] - Plumas Bancorp, Northrim Bancorp, Heritage Commerce
Risk Flags(3)
- [SYSTEMIC RISK]▼
Uniform lack of disclosure details across all 34 filings obscures potential C-suite departures or governance voids
- [SECTOR RISK]▼
Medium risk concentration in higher-materiality cases (e.g., Super Micro, Aon) amid unknown reasons for changes
- ▼
Single-day filing surge raises flags for correlated underlying pressures like performance issues or regulatory probes
Opportunities(4)
- ◆
Proactive monitoring of biotech cluster (9 filings) for undervalued appointment catalysts post-detail release
- ◆
Alpha potential in Super Micro Computer (5/10 materiality) if filings reveal strategic hires enhancing tech growth
- ◆
Long opportunities in banking names (Plumas, Northrim, Heritage) assuming routine low-impact successions
- ◆
Short-term trading plays on follow-up 8-K/A amendments disclosing positive compensatory arrangements
Sector Themes(3)
- ◆
Biotech/Pharma dominance with ~9 filings signals potential pipeline-driven leadership refreshes or funding-related churn
- ◆
Technology/hardware cluster (~7 filings) hints at sector-wide talent mobility amid innovation cycles
- ◆
Financial/banking uptick (~5 filings) reflects possible regulatory or M&A-tied executive realignments
Watch List(4)
- 👁
Super Micro Computer - Highest materiality (5/10); large filing size suggests detailed exhibits warranting scrutiny
- 👁
Aon plc - Materiality 4/10 in insurance giant; governance implications for institutional portfolios
- 👁
Biotech cluster (MiNK, Indaptus, Genelux, Vor) - Volume indicates sector trend; track for CEO/CFO specifics
- 👁
THUMZUP Media & XTI Aerospace - Multi-item filings (e.g., votes, operations) may correlate changes to broader events
Filing Analyses(34)
02-01-2026
Aon plc filed a Form 8-K on January 2, 2026 (AccNo: 0001193125-26-000263, Size: 524 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary.
02-01-2026
Plumas Bancorp filed a Form 8-K on 2026-01-02 (AccNo: 0001437749-26-000014, Size: 175 KB) reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No details on specific officers, positions, reasons, appointments, resignations, or quantitative data are disclosed in the provided filing summary. Event type is Officer Change; sector not specified.
02-01-2026
Northrim Bancorp Inc filed a Form 8-K on January 02, 2026 (AccNo: 0001163370-26-000002, Size: 743 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are disclosed in the provided filing summary.
02-01-2026
Teledyne Technologies Inc. filed a Form 8-K on January 02, 2026 (AccNo: 0001094285-26-000004, size: 139 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as officer names, titles, reasons for change, internal/external status, timing, compensation, or quantitative financial metrics are provided. Sector is not specified.
02-01-2026
Sandisk Corp filed an 8-K on January 2, 2026 (AccNo: 0001628280-26-000127, Size: 143 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
02-01-2026
MiNK Therapeutics, Inc. filed a Form 8-K on January 02, 2026 (AccNo: 0001193125-26-000916, Size: 150 KB) under Item 5.02 disclosing an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, timing, or compensation are provided. Sector is not specified.
02-01-2026
Creative Realities, Inc. filed an 8-K on 2026-01-02 (AccNo: 0001437749-26-000084, Size: 169 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and matters submitted to a vote of security holders under Item 5.07. No specific details on positions affected, individuals involved, reasons for change, board outcomes, or quantitative data are provided in the filing summary. Sector is not specified.
02-01-2026
Indaptus Therapeutics, Inc. filed a Form 8-K on January 02, 2026 (AccNo: 0001493152-26-000106, Size: 198 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, or reasons provided. Sector not specified.
02-01-2026
Genasys Inc. filed a Form 8-K on January 2, 2026 (AccNo: 0001193125-26-000921, size 142 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided. Sector is not specified.
02-01-2026
Southwest Gas Holdings, Inc. disclosed an officer change via Form 8-K filed on 2026-01-02 (AccNo: 0001193125-26-000920, Size: 138 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 7.01 (Regulation FD Disclosure). No specific details on the officer's name, title, reason for change, or compensatory arrangements are provided.
02-01-2026
The company filed a Form 8-K on January 2, 2026 (AccNo: 0001193125-26-000908, Size: 121 KB) under Item 5.02 disclosing an officer change event dated January 2, 2026. No specific details on the affected officer's position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided. Sector is not specified.
02-01-2026
Vor Biopharma Inc. filed a Form 8-K on 2026-01-02 (AccNo: 0001193125-26-000905, Size: 245 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are stated. Sector not specified.
02-01-2026
Castellum, Inc. filed an 8-K on January 2, 2026 (AccNo: 0001877939-26-000004, Size: 146 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or compensation are disclosed in the provided summary.
02-01-2026
Invitation Homes Inc. filed a Form 8-K on January 02, 2026 (AccNo: 0001687229-26-000004, Size: 155 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data are provided. Sector is not specified.
02-01-2026
NRG Energy, Inc. filed a Form 8-K on January 02, 2026 (AccNo: 0001104659-26-000204, Size: 244 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer(s) involved, position, reason for change, or terms are stated in the provided filing summary. Sector is not specified.
02-01-2026
CROSS COUNTRY HEALTHCARE INC filed a Form 8-K on January 02, 2026 (AccNo: 0001628280-26-000149, Size: 414 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary. Sector is not specified.
02-01-2026
Photronics Inc filed a Form 8-K on 2026-01-02 (AccNo: 0001140361-26-000196, Size: 180 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are provided. All quantitative data, named individuals, and further context are NOT_DISCLOSED.
02-01-2026
Super Micro Computer, Inc. disclosed an officer change event via SEC Form 8-K filed on 2026-01-02 (AccNo: 0001375365-26-000002, Size: 3 MB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided in the summary.
02-01-2026
GENELUX Corp filed a Form 8-K on 2026-01-02 (AccNo: 0001493152-26-000115, Size: 316 KB) disclosing an officer or director change under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected position, individual names, reasons, or quantitative data are provided in the filing summary.
02-01-2026
Enova International, Inc. disclosed an officer change via Form 8-K filed on 2026-01-02 (AccNo: 0001193125-26-000953, Size: 163 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are stated in the provided filing summary. Sector not specified.
02-01-2026
CNX Resources Corp filed a Form 8-K on January 02, 2026 (AccNo: 0001070412-26-000004, Size: 201 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
02-01-2026
Company filed an 8-K on 2026-01-02 (AccNo: 0001193125-26-000973, Size: 127 KB) under Item 5.02 disclosing an officer change event dated January 02, 2026. No details on the specific officer position, appointment or resignation status, reasons, or any quantitative data are stated. Sector not specified.
02-01-2026
THUMZUP MEDIA Corp filed an 8-K on January 02, 2026 (AccNo: 0001493152-26-000147, Size: 543 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position affected, reason for change, or financial metrics are disclosed in the provided information. Sector is not specified.
02-01-2026
Heritage Commerce Corp filed an 8-K on January 2, 2026 (AccNo: 0001104659-26-000215, Size: 188 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 covers Financial Statements and Exhibits. No specific details on the officer's position, appointment/resignation, reason, or compensation provided.
02-01-2026
Apimeds Pharmaceuticals US, Inc. disclosed an officer change via Form 8-K filed on January 2, 2026 (AccNo: 0001213900-26-000464, Size: 192 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. No specific details on the affected position, individuals involved, reasons for change, or any quantitative data are provided in the available information. Sector is not specified.
02-01-2026
Teucrium Commodity Trust filed an 8-K on 2026-01-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Accession number: 0001437749-26-000107; file size: 197 KB. No specific names, positions, reasons, or quantitative details provided in the available summary.
02-01-2026
Ceribell, Inc. disclosed an officer change via Form 8-K filed on 2026-01-02 (AccNo: 0001193125-26-000994, Size: 161 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or quantitative data are provided in the available information.
02-01-2026
OneStream, Inc. filed a Form 8-K on January 2, 2026 (AccNo: 0001193125-26-001003, Size: 155 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected position, individual involved, nature of change (appointment or resignation), reasons, or any quantitative data are provided. Sector is not specified.
02-01-2026
The company filed an 8-K on January 02, 2026 (AccNo: 0001104659-26-000235, Size: 246 KB) under Item 5.02 disclosing an officer change event dated January 02, 2026. No specific details on the officer's name, title, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the available filing excerpt. Sector is not specified.
02-01-2026
XTI Aerospace, Inc. filed a Form 8-K on January 2, 2026 (AccNo: 0001213900-26-000495, Size: 534 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also covers Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed.
02-01-2026
Sonoma Pharmaceuticals, Inc. filed an 8-K on January 2, 2026 (AccNo: 0001683168-26-000027, Size: 193 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual, nature of change (appointment or resignation), reasons, or compensation are provided. Sector is not specified.
02-01-2026
Riot Platforms, Inc. filed a Form 8-K on January 2, 2026 (AccNo: 0001104659-26-000248, Size: 598 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, nature of change, reasons, or quantitative data are provided in the summary.
02-01-2026
Tenaya Therapeutics, Inc. filed a Form 8-K on 2026-01-02 (AccNo: 0001193125-26-001065, Size: 155 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are stated.
02-01-2026
Petros Pharmaceuticals, Inc. filed a Form 8-K on January 02, 2026 (AccNo: 0001104659-26-000236, Size: 182 KB) disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, nature of change (appointment or resignation), reasons, or any quantitative impacts are stated in the provided filing summary. Sector is not specified.
Get daily alerts with 4 investment signals, 3 risk alerts, 4 opportunities and full AI analysis of all 34 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings